Can a sleep drug help people with PSP rest better?
NCT ID NCT04014387
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested two sleep medications (suvorexant and zolpidem) against a placebo in 40 adults with Progressive Supranuclear Palsy (PSP). The goal was to see if targeting the brain's wake-promoting system could improve sleep quality and daytime well-being. Each person tried all three treatments for one week each, with a week off in between. The study measured sleep patterns and overall health to find a safe and effective option for better rest.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROGRESSIVE SUPRANUCLEAR PALSY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of California- San Francisco
San Francisco, California, 94158, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a brain disease change behavior years before diagnosis?
- High-Resolution brain scans aim to unmask Tau's role in Parkinson's
- Wearable sensors aim to catch neurodegenerative decline in real time
- Sleep hormone melatonin put to the test against lupus fatigue and inflammation
- Experimental antibody aims to tame rare brain disorder
- Can early jaw treatment in children prevent major surgery later?